Senores Pharmaceuticals expands US footprint with Roflumilast ANDA acquisition

Senores Pharmaceuticals Limited has taken a significant step in its US expansion strategy by acquiring an Abbreviated New Drug Application (ANDA) for Roflumilast 250 mcg ... Read More